Skip to content

Application of lntravenous lidocaine in obese patients undergoing painless gastrointestinal endoscopy

Application of lntravenous lidocaine in obese patients undergoing painless gastrointestinal endoscopy

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500103502
Enrollment
Unknown
Registered
2025-05-30
Start date
2024-10-08
Completion date
Unknown
Last updated
2025-06-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Obese Patients Painless Gastrointestinal Endoscopy

Interventions

Group A :Lidocaine injection
Group B:Intravenous injection of physiological saline

Sponsors

Yantai Affiliated Hospital of Binzhou Medical College
Lead Sponsor

Eligibility

Sex/Gender
All
Age
26 Years to 72 Years

Inclusion criteria

Inclusion criteria: Patients with ASA grade II-III, BMI >= 30, unlimited gender, and age between 26 and 72 years old.

Exclusion criteria

Exclusion criteria: ASA Grade > III,history of anaphylaxis to narcotic drugs, hearing impairment, Alzheimer's disease and other causes of communication disorders, serious heart, lung, liver, kidney and other functional abnormalities

Design outcomes

Primary

MeasureTime frame
Dose of propofol ;Incidence of bucking;Incidence of hypoxemia;Number of somatic reaction;BIS value;Incidence of dizzy;

Secondary

MeasureTime frame
Incidence of abdominal pain;Awakening Time;

Countries

China

Contacts

Public ContactQin zhichao

Yantai Affiliated Hospital of Binzhou Medical College

254162132@qq.com+86 159 6516 2783

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026